J&J Buys Abbott Medical for $4.3 Billion
By MedTech Intelligence Staff
The deal is part of Johnson & Johnson's strategy to grow its vision care business.
Johnson & Johnson is reportedly acquiring Abbott Medical for $4.3 billion. The cash transaction is part of the company's strategy to grow its vision care business.
We've been actively and strategically shaping our portfolio, which has recently focused on developing leadership positions in cardiovascular devices and expanding diagnostics," said Miles D. White, chairman and chief executive officer of Abbott in a press release. "Our vision care business will be well-positioned for continued success and advancement with Johnson & Johnson, and I'd like to thank our employees for building a successful business."
The transaction is expected to close during the first quarter of 2017.
Abbott Medical Johnson & Johnson vision
MedTech Intelligence Staff
The MedTech Intelligence staff consists of freelance journalists and industry contributing writers with decades of experience in covering medical device issues under the categories of business, market trends, product development, quality, regulatory, and operations.
You can contact our writing staff via our Contact Page.